ArticleBiomolecules2026
Novel Dorsomorphin Derivatives: Molecular Modeling, Synthesis, and Bioactivity Evaluation.
Evangelia N Tzanetou, Sandra Liekens, Konstantinos M Kasiotis, Nikolas Fokialakis, Nikolaos Tsafantakis, Raul SanMartin, Haralampos Tzoupis, Konstantinos D Papavasileiou, Antreas Afantitis, Serkos A Haroutounian
Abstract read
In one paragraphArticle in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Evangelia N TzanetouLaboratory of Nutritional Physiology and Feeding, Department of Animal Sciences and Aquaculture, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece.ORCID 0000-0001-9568-2283 Sandra LiekensRega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium.
Konstantinos M KasiotisLaboratory of Nutritional Physiology and Feeding, Department of Animal Sciences and Aquaculture, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece.ORCID 0000-0001-6631-0667 Nikolas FokialakisDepartment of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece.ORCID 0000-0001-7028-1870 Nikolaos TsafantakisDepartment of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, University of Athens, Panepistimiopolis, Zografou, 15771 Athens, Greece.ORCID 0000-0002-6829-9673 Raul SanMartinDepartment of Organic and Inorganic Chemistry, Faculty of Science and Technology, University of the Basque Country, (UPV-EHU), 48940 Leioa, Spain.ORCID 0000-0002-8105-1947 Konstantinos D PapavasileiouDepartment of ChemoInformatics, NovaMechanics Ltd., Nicosia 1070, Cyprus.
Serkos A HaroutounianLaboratory of Nutritional Physiology and Feeding, Department of Animal Sciences and Aquaculture, Agricultural University of Athens, Iera Odos 75, 11855 Athens, Greece.ORCID 0000-0002-5841-3460 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Dorsomorphin, a pyrazolo[1,5-
Indexed as
Antineoplastic AgentsProtein Kinase InhibitorsPyrazolesPyrimidinesAnimalsCattleCell Line, TumorCell ProliferationEndothelial CellsHeLa CellsHumansMiceModels, MolecularMolecular Docking SimulationAntineoplastic AgentsdorsomorphinProtein Kinase InhibitorsPyrazolesPyrimidinesantiproliferativedorsomorphinmicrowave-assisted synthesismolecular modelingpyrazolo[1,5-a]pyrimidine
Identifiers
PMID41594685
PMCPMC12839441
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390